R. Rulach

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic

Corinne Faivre‐Finn, John D. Fenwick, K. Franks et al. · Clinical Oncology · 2020 · 63 citations · Full text

Medicine, Oncology, Radiation Oncology +17

An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer

R. Rulach, David Ball, Kevin Lee Min Chua et al. · Advances in Radiation Oncology · 2021 · 59 citations · Full text

Medicine, Oncology, Radiation Oncology +16

12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers

R. Rulach, Suyun Zhou, Fraser Hendry et al. · Oral Oncology · 2019 · 47 citations

Medicine, Oncology, Radiation Oncology +8

Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer

R. Rulach, Stephen McKay, S. Neilson et al. · British Journal of Urology · 2017 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck

Claire Paterson, Maureen Thomson, Brian T. Caldwell et al. · British Journal of Oral and Maxillofacial Surgery · 2019 · 13 citations · Full text

Medicine, Oncology, Radiation Oncology +12